CClinicalTrials.gg
CompletedNCT03520907Updated Aug 13, 2019

The Comparison of the Transversalis Fascia Plane Block With Ilioinguinal/Iliohypogastric Nerve Block

An interventional study of Transversalis Fascia Plane Block and Ilioinguinal/iliohypogastric Nerve Block in Postoperative Pain, Inguinal Hernia Unilateral and Children, Only, sponsored by Kazuhiko Okuyama, MD. Completed at 1 site in Japan. Open to participants aged 2 Years to 13 Years. Per ClinicalTrials.gov, last updated 2019-08-13.

Sponsored by Kazuhiko Okuyama, MD · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
2 Years to 13 Years
Sex
All
01

Study summary

This study compares the transversalis fascia plane block with the ilioinguinal/iliohypogastric nerve block in children undergoing hernia repair surgery.

Half of participants will receive the transversalis fascia plane block, while the other will receive the ilioinguinal/iliohypogastric nerve block.

Read the detailed description

The ilioinguinal/iliohypogastric nerve block (II/IH B)is a widely used regional anesthesia technique in inguinal hernia repair surgery. However, this block provides limited analgesia during and after surgery, and the patients feel pain when walking. The transversalis fascia plane block (TFPB) is a recently developed technique and several case reports presented its efficacy for inguinal repair surgery in adult patients. It may block not only ilioinguinal and iliohypogastric nerves but also splanchnic nerves, which is conveyed via the thoracolumbar fascia. Therefore, we compare the effect of the TFPB and II/IH B on postoperative pain and walking form.

02

Conditions studied

  • Postoperative Pain
  • Inguinal Hernia Unilateral
  • Children, Only

Keywords

  • transversalis fascia
  • ilioinguinal/iliohypogastric nerve
  • inguinal hernia repair
  • children
03

In context

Pain, Postoperative

5,095 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 80 is close to the median of 75 across 4,346 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

This is the only study on the registry with Kazuhiko Okuyama, MD as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • the patients undergoing unilateral open hernia repair surgery

Exclusion criteria

Exclusion Criteria:

  • known allergy to local anesthetics, psychomotor retardation, anti-epileptic drugs usage, anti-inflammatory drug usage
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    Transversalis Fascia Plane Block

    receive transversalis fascia plane block with 0.4 ml/kg of 0.25% levobupivacaine after establishment of general anesthesia.

    Drug: Transversalis Fascia Plane Block

  • Active comparator
    Ilioinguinal/iliohypogastric Nerve Block

    receive ilioinguinal/iliohypogastric nerve block with 0.1 ml/kg of 0.25% levobupivacaine after establishment of general anesthesia.

    Drug: Ilioinguinal/iliohypogastric Nerve Block

Interventions

  • DrugTransversalis Fascia Plane Block

    block will be performed under real-time ultrasound guidance

    Also known as: TFPB

  • DrugIlioinguinal/iliohypogastric Nerve Block

    block will be performed under real-time ultrasound guidance

    Also known as: II/IH B

06

What researchers measure

Primary outcomes

  1. walking appearance

    scoring a way of walking; 0: brisk walk, big step, able to skip (= no pain) to 5: not able to stand up ( = worst pain)

    Time frame: 3 to 5 hours after surgery

Secondary outcomes

  1. FLACC (face, legs, activity, cry, consolability) score

    behavioral pain scale in children. Each category has 0 to 2 score; Total 0 (no pain) to 10 (worst)

    Time frame: 3 to 5 hours after surgery

  2. Faces Pain Scale revised

    self-reported pain score. Children choose a face from six faces.

    Time frame: 3 to 5 hours after surgery

  3. additional pain curer usage

    request or necessity of administration of acetaminophen or flurbiprofen

    Time frame: up to 5 hours after surgery

Other outcomes

  1. intraoperative heart rate changes

    heart rate during surgery

    Time frame: just before surgery start, one minute after incision, maximum value during surgery

  2. intraoperative respiratory rate changes

    respiratory rate during surgery

    Time frame: just before surgery start, one minute after incision, maximum value during surgery

07

Study locations

1 site
  • Ibaraki Children's Hospital
    Mito, Ibaraki 311-4145, Japan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03520907
Lead sponsor
Kazuhiko Okuyama, MD
Responsible party
Kazuhiko Okuyama, MD (Chief Anesthesiologist, Ibaraki Children's Hospital) — Sponsor-investigator
First posted
May 11, 2018
Start date
Apr 26, 2018
Primary completion
Jun 27, 2019
Completion
Jun 27, 2019
Last update
Aug 13, 2019

Study contacts

Kazuhiko Okuyama, MD
study director · Ibaraki Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion